CT EMERGING INFECTIONS PROGRAM REFERENCE LIST:
Candidemia Surveillance Publications
Arthington-Skaggs, B. A., W. Lee-Yang, M. A. Ciblak, J. P. Frade, M. E. Brandt, R. A. Hajjeh, L. H.
Harrison, A. N. Sofair, D. W. Warnock and G. Candidemia Active Surveillance (2002).
"Comparison of visual and spectrophotometric methods of broth microdilution MIC end
point determination and evaluation of a sterol quantitation method for in vitro
susceptibility testing of fluconazole and itraconazole against trailing and nontrailing
Candida isolates." Antimicrobial Agents & Chemotherapy 46(8): 2477-2481.
http://www.ncbi.nlm.nih.gov/pubmed/12121921
Brandt, M. E., L. H. Harrison, M. Pass, A. N. Sofair, S. Huie, R. K. Li, C. J. Morrison, D. W.
Warnock and R. A. Hajjeh (2000). "Candida dubliniensis fungemia: the first four cases in
North America." Emerging Infectious Diseases 6(1): 46-49.
http://www.ncbi.nlm.nih.gov/pubmed/10653569
Hajjeh, R. A., A. N. Sofair, L. H. Harrison, G. M. Lyon, B. A. Arthington-Skaggs, S. A. Mirza, M.
Phelan, J. Morgan, W. Lee-Yang, M. A. Ciblak, L. E. Benjamin, L. T. Sanza, S. Huie, S. F.
Yeo, M. E. Brandt and D. W. Warnock (2004). "Incidence of bloodstream infections due
to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in
a population-based active surveillance program." Journal of Clinical Microbiology 42(4):
1519-1527. http://www.ncbi.nlm.nih.gov/pubmed/15070998
Lott, T. J., R. E. Fundyga, M. E. Brandt, L. H. Harrison, A. N. Sofair, R. A. Hajjeh and D. W.
Warnock (2003). "Stability of allelic frequencies and distributions of Candida albicans
microsatellite loci from U.S. population-based surveillance isolates." Journal of Clinical
Microbiology 41(3): 1316-1321. http://www.ncbi.nlm.nih.gov/pubmed/12624076
Morgan, J., M. I. Meltzer, B. D. Plikaytis, A. N. Sofair, S. Huie-White, S. Wilcox, L. H. Harrison, E.
C. Seaberg, R. A. Hajjeh and S. M. Teutsch (2005). "Excess mortality, hospital stay, and
cost due to candidemia: a case-control study using data from population-based
candidemia surveillance.[Erratum appears in Infect Control Hosp Epidemiol. 2005
Aug;26(8):675]." Infection Control & Hospital Epidemiology 26(6): 540-547.
http://www.ncbi.nlm.nih.gov/pubmed/16018429
Park, B. J., B. A. Arthington-Skaggs, R. A. Hajjeh, N. Iqbal, M. A. Ciblak, W. Lee-Yang, M. D.
Hairston, M. Phelan, B. D. Plikaytis, A. N. Sofair, L. H. Harrison, S. K. Fridkin and D. W.
Warnock (2006). "Evaluation of amphotericin B interpretive breakpoints for Candida
bloodstream isolates by correlation with therapeutic outcome." Antimicrobial Agents &
Chemotherapy 50(4): 1287-1292. http://www.ncbi.nlm.nih.gov/pubmed/16569842
Smith, P. B., J. Morgan, J. D. Benjamin, S. K. Fridkin, L. T. Sanza, L. H. Harrison, A. N. Sofair, S.
Huie-White and D. K. Benjamin, Jr. (2007). "Excess costs of hospital care associated with
neonatal candidemia." Pediatric Infectious Disease Journal 26(3): 197-200.
http://www.ncbi.nlm.nih.gov/pubmed/17484214
Sofair, A. N., G. M. Lyon, S. Huie-White, E. Reiss, L. H. Harrison, L. T. Sanza, B. A. ArthingtonSkaggs and S. K. Fridkin (2006). "Epidemiology of community-onset candidemia in
Connecticut and Maryland." Clinical Infectious Diseases 43(1): 32-39.
http://www.ncbi.nlm.nih.gov/pubmed/16758415
Yeo, S. F., S. Huie, A. N. Sofair, S. Campbell, A. Durante and B. Wong (2006). "Measurement of
serum D-arabinitol/creatinine ratios for initial diagnosis and for predicting outcome in
an unselected, population-based sample of patients with Candida fungemia." Journal of
Clinical Microbiology 44(11): 3894-3899.
http://www.ncbi.nlm.nih.gov/pubmed/16957030